A bivalent antihypertensive vaccine targeting L-type calcium channels and angiotensin AT1 receptors.
Wu H, Wang Y, Wang G, Qiu Z, Hu X, Zhang H, Yan X, Ke F, Zou A, Wang M, Liao Y, Chen X.
Wu H, et al. Among authors: wang g, wang y, wang m.
Br J Pharmacol. 2020 Jan;177(2):402-419. doi: 10.1111/bph.14875. Epub 2019 Dec 12.
Br J Pharmacol. 2020.
PMID: 31625597
Free PMC article.